These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 25234358

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer.
    Chen X, Li Q, Liu X, Liu C, Liu R, Rycaj K, Zhang D, Liu B, Jeter C, Calhoun-Davis T, Lin K, Lu Y, Chao HP, Shen J, Tang DG.
    Clin Cancer Res; 2016 Sep 01; 22(17):4505-16. PubMed ID: 27060154
    [Abstract] [Full Text] [Related]

  • 23. MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2.
    Scaravilli M, Porkka KP, Brofeldt A, Annala M, Tammela TL, Jenster GW, Nykter M, Visakorpi T.
    Prostate; 2015 Jun 01; 75(8):798-805. PubMed ID: 25731699
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1.
    Gao F, Xu Q, Tang Z, Zhang N, Huang Y, Li Z, Dai Y, Yu Q, Zhu J.
    J Transl Med; 2022 Aug 02; 20(1):346. PubMed ID: 35918733
    [Abstract] [Full Text] [Related]

  • 26. MicroRNA in prostate cancer: Practical aspects.
    Patil PA, Magi-Galluzzi C.
    Histol Histopathol; 2015 Dec 02; 30(12):1379-96. PubMed ID: 26186079
    [Abstract] [Full Text] [Related]

  • 27. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
    Yang B, Liu Z, Ning H, Zhang K, Pan D, Ding K, Huang W, Kang XL, Wang Y, Chen X.
    Cancer Biomark; 2016 Jul 08; 17(2):223-30. PubMed ID: 27434290
    [Abstract] [Full Text] [Related]

  • 28. Detection of miRNAs in urine of prostate cancer patients.
    Stuopelytė K, Daniūnaitė K, Jankevičius F, Jarmalaitė S.
    Medicina (Kaunas); 2016 Jul 08; 52(2):116-24. PubMed ID: 27170485
    [Abstract] [Full Text] [Related]

  • 29. miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence.
    Jiao L, Deng Z, Xu C, Yu Y, Li Y, Yang C, Chen J, Liu Z, Huang G, Li LC, Sun Y.
    J Cell Physiol; 2014 Jul 08; 229(7):834-44. PubMed ID: 24243035
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.
    Spahn M, Kneitz S, Scholz CJ, Stenger N, Rüdiger T, Ströbel P, Riedmiller H, Kneitz B.
    Int J Cancer; 2010 Jul 15; 127(2):394-403. PubMed ID: 19585579
    [Abstract] [Full Text] [Related]

  • 34. Determination of miRNA expression profile in patients with prostate cancer and benign prostate hyperplasia.
    Sancer O, Koşar PA, Tefebaşı MY, Ergün O, Demir M, Koşar A.
    Turk J Med Sci; 2022 Jun 15; 52(3):788-795. PubMed ID: 36326314
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
    Leidinger P, Hart M, Backes C, Rheinheimer S, Keck B, Wullich B, Keller A, Meese E.
    Tumour Biol; 2016 Aug 15; 37(8):10177-85. PubMed ID: 26831660
    [Abstract] [Full Text] [Related]

  • 37. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL, Tobiasen H, Holm A, Schepeler T, Ostenfeld MS, Thorsen K, Rasmussen MH, Birkenkamp-Demtroeder K, Sieber OM, Gibbs P, Lubinski J, Lamy P, COLOFOL steering group, Laurberg S, Oster B, Hansen KQ, Hagemann-Madsen R, Byskov K, Ørntoft TF, Andersen CL.
    Int J Cancer; 2013 Jul 15; 133(1):67-78. PubMed ID: 23280316
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer.
    Huang X, Yuan T, Liang M, Du M, Xia S, Dittmar R, Wang D, See W, Costello BA, Quevedo F, Tan W, Nandy D, Bevan GH, Longenbach S, Sun Z, Lu Y, Wang T, Thibodeau SN, Boardman L, Kohli M, Wang L.
    Eur Urol; 2015 Jan 15; 67(1):33-41. PubMed ID: 25129854
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.